Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Physics in Medicine and Biology|May 21, 2013
Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injectionJ Rahmer, A Antonelli, C Sfara, et al.
Nucleic Acids Research|December 15, 1996
An enhancer LEF-1/TCF-1 site is essential for insertion site-independent transgene expression in thymusT L Haynes, M B Thomas, M R Dusing, et al.
Frontiers in Immunology|November 29, 2023
Uterine Nodal expression supports maternal immunotolerance and establishment of the FOXP3<sup>+</sup> regulatory T cell population during the preimplantation periodSarah Yull, Shiva Shafiei, Craig B Park, et al.
Anticancer Research|June 12, 1999
Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinomaD Elsässer, H Stadick, S Stark, et al.
Journal of Immunological Methods|February 27, 2001
Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodiesB Stockmeyer, D Elsässer, M Dechant, et al.
Mechanisms of Development|July 1, 1997
Spx1, a novel X-linked homeobox gene expressed during spermatogenesisW W Branford, G Q Zhao, M T Valerius, et al.
Molecular and Cellular Biology|February 1, 1995
Dissecting a locus control region: facilitation of enhancer function by extended enhancer-flanking sequencesB J Aronow, C A Ebert, M T Valerius, et al.
Blood|August 1, 1993
Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapyT Valerius, R Repp, T P de Wit, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1996
In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effectsH M Lorenz, C Antoni, T Valerius, et al.
Journal of Hematotherapy|October 1, 1995
G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210)R Repp, T Valerius, G Wieland, et al.
Pageof 5